Jeff Missling News Today : Breaking News, Live Updates & Top Stories | Vimarsana

ProMed Pharma Acquires SpineThera Manufacturing Capabilities and an Option to License Intellectual Property

ProMed Pharma Acquires SpineThera Manufacturing Capabilities and an Option to License Intellectual Property
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United statesMaple groveJim arpsJeff misslingAnimal healthSpinethera incPromed pharmaBusiness development at promed pharmaWomen healthLicense intellectualUmed pharmaChief executive officerBusiness developmentComplex genericsMedical alley

ProMed Pharma Acquires SpineThera Manufacturing Capabilities and an Option to License Intellectual Property

ProMed Pharma Acquires SpineThera Manufacturing Capabilities and an Option to License Intellectual Property
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesMaple groveJim arpsJeff misslingPromed pharmaWomen healthBusiness development at promed pharmaSpinethera incAnimal healthUmed pharmaChief executive officerBusiness developmentComplex genericsMedical alley

ProMed Pharma Acquires SpineThera Manufacturing Capabilities and an Option to License Intellectual Property

United statesMaple groveJim arpsJeff misslingSpinethera incWomen healthPromed pharmaAnimal healthBusiness development at promed pharmaUmed pharmaChief executive officerBusiness developmentComplex genericsMedical alley

SpineThera Celebrates Milestone Achievement with 6th Patent Issued by the US Patent and Trademark Office

SpineThera Celebrates Milestone Achievement with 6th Patent Issued by the US Patent and Trademark Office
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesJeff misslingSpinethera incTrademark officeUnited states patentMedical alley

SpineThera Announces Breakthrough Market Research Results for SX600 in the Management of Sciatica Pa

PLYMOUTH, Minn. (BUSINESS WIRE) SpineThera, Inc., a leading clinical-stage pharmaceutical company specializing in innovative injectable drugs, is thrilled to announce groundbreaking results from an independent market research study. The study underscores the enormous potential of SpineThera's SX600, a novel formul.

United statesJeff misslingSpinethera incMedical alley